Revenue growth masks PAT collapse; margin recovery hinges on Thailand turnaround
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Guided ABS expansion 'FY27 completion' but no precision given; capex in Jan-Mar window; analyst skepticism on Thailand breakeven timeline warranted.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Styrenix is in a multi-year turnaround: revenue growth and ABS capacity expansion provide long-term upside, but consolidated PAT crashed -48.2% YoY as Thailand losses (acquired Jan 2025) swamped India's INR51.2 Cr profit. Near-term margin recovery hinges on Thailand cost restructuring (2+ years estimated) and raw material volatility easing—both uncertain.
₹993.5 Cr
Revenue · +24.4% YoY₹23.2 Cr
Reported PAT · −48.2% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
ABS volumes up significantly, improving capacity utilization
MISSQ2 ABS sales volume recovered but profit down 48.2% YoY; India PAT INR51.2 Cr vs consolidated INR23 Cr due to Thailand losses
India margin improvement through cost management and HIPS volume growth
OVERSTATEDConsolidated NPM collapsed to 2.3% from prior year; India stand-alone PAT INR51.2 Cr positive but masked by Thailand losses
Phase 1 ABS expansion expected to be operational by end of FY27 with significant EBITDA upside
PartialNo timeline given for commissioning; CFO confirmed capex will go live 'by end of year' but no precision on when capacity will be fully absorbed
Thailand business will be structurally profitable and multi-year trajectory is improving
OVERSTATEDThailand now 7 quarters under management; still loss-making with no clear breakeven timeline; management says 'two years' for improvement, margins still weak
New ABS grades (ASALAC, STYROLOY) expanding addressable market
METGrades launched and approvals ongoing; only gradual volume ramp; no quantified market size or margin benefit provided
Earnings quality
What changed since the last call
Thailand contribution now consolidated; drags PAT visibly
DowngradePrior call (implied H1 FY27 strength with PAT ₹188.5 Cr H1) masked small Thailand losses. Now ₹23.2 Cr consolidated Q2 vs ₹51.2 Cr India standalone reveals ₹28 Cr+ quarterly loss in Thailand. Drag larger than guided 'ramp-up' tone.
Polystyrene demand weaker; GPPS volumes consciously reduced
DowngradeManagement admits choosing NOT to chase non-OEM GPPS demand in Q2 due to price volatility and speculative market. Volumes lower; reflects demand weakness and pricing discipline.
ABS expansion capex timeline remains vague (Q3-Q4 FY27 'commissioning' now, but ramp-up uncertain)
NeutralNo change in stated completion window, but analyst questions on when full utilization happens; CFO confirmed 15–20 day lag for online capacity but no breakeven guidance.
New ABS grades (ASALAC, STYROLOY) launched; approvals ongoing
NewTwo new specialty grades now in market with approvals in progress; expected to drive margin upside post-2027. Concrete mechanism for future positioning but no near-term margin benefit yet.
The Q&A
Analysts pressed hard on Thailand breakeven (Nirav Jimudia: 'two years still not clear, when will demand/cost match?'), capex scale-up (Ronak Chheda: 'how long to hit 100% utilization?'), and competitive intensity (Aditya Khetan: 'competitor plants ramping ABS—why should we win?'). Management held to 'two-year trajectory' and 'cost management' but offered no credible near-term margin bridge. Tone was defensive on Thailand; defensive on polystyrene. Analysts seemed skeptical.
ABS imports, capacity pricing — Nirav Jimudia, Anvil Wealth
AnsweredRefrigeration liner ABS grade (unique in India currently). Can produce ~30,000–40,000 tons annually. Other grades exist but our competitive positioning is in niche refrigeration + automotive segments. Margin advantage from specialization, not volume.
Polystyrene volume ramp-up — Nirav Jimudia, Anvil Wealth
PartialGPPS non-OEM demand uncertain; we chose not to participate in speculative volumes in Q2 due to raw material risk. H2 volumes should be in line with Q2 on annualized basis. Management call—no aggressive volume assumption.
Thailand breakeven timeline — Aditya Khetan, SMIFS Institutional Equities
AnsweredRealistic is 2–2.5 years for profitability given cost structure, product mix rebalancing, and new capacity benefits. China export also not started yet. Business makes sense structurally long-term but near-term patience required.
Gross margin trajectory — Ronak Chheda, Awriga Capital
PartialGross margins on annualized basis align with historical levels if Q1 anomalies removed. Capex will go live by end of FY27, but exact month uncertain (Jan-March window). Scale-up lag of 1–2 quarters for full utilization expected.
New grades, market expansion — Nirav Jimudia, Anvil Wealth
AnsweredBoth. ASALAC for automotive/EV thermal systems + solar. STYROLOY blends for appliances. Approvals in progress; gradual volume ramp expected. Not a volume jump but margin accretion over time.
Thailand product mix, regional demand — Ashwin Reddy, Samatva Investments
AnsweredProduct mix rebalancing ongoing; specialized grades still ramp slowly. Competitive intensity from Korea/Taiwan but local pricing power exists due to specialization. Sales mix: ~40–50% China, ~20–25% Thailand domestic, ~25–35% Japan/Vietnam/other regions.
ABS capacity utilization, competitive positioning — Aditya Khetan, SMIFS Institutional Equities
PartialOur unique positioning is in specialty grades (refrigeration liner, niche appliance grades) where we have limited competition. Commodity grades have less margin but don't compete directly. Volumes will grow gradually, not capture full market.
Market share maintenance — Meet Parekh, Mihir Asia & Corporation
PartialDumping has occurred; import duties removed then reinstated. Local manufacturers still prefer Indian suppliers for quality/consistency. Pricing pressure exists in commodity grades; specialty grades have better pricing power. Market share stable YTD.
Thailand cash loss in Q2 — Meet Parekh, Mihir Asia & Corporation
AnsweredQ2 is near the base case. Product mix rebalancing and cost actions have offset some pressure. Improvements likely in H2 as volume ramp and cost savings take hold, but full recovery is 2+ years.
Volume guidance, FY27-FY28 outlook — Aditya Khetan, SMIFS Institutional Equities
DodgedNo forward-looking guidance on volume targets. Focus is on capacity utilization and margin improvement. New ABS capacity coming online will add incrementally but timeline for full absorption is not given.
Guidance
No explicit FY27/FY28 revenue target provided
LowManagement confirmed Phase 1 ABS expansion 'on track for FY27 completion' (Q3-Q4 timeline) but no volume ramp or revenue uplift quantified.
Gross margins expected to normalize at historical levels post-Q1 anomaly
MediumCFO stated Q2 margins 'slightly better YoY on absolute spread' but acknowledged raw material volatility persists. No NPM recovery timeline given.
ABS expansion to deliver EBITDA upside; timeline unspecified
LowNo margin bridge or EBITDA target stated. Management said 'long-term value' but admits cost reduction in Thailand is 2+ years away.
Phase 1 capex completion by end of FY27 (Jan-March 2027 window)
MediumMD stated 'very close to it' and capex will go live 'by end of year' but exact month uncertain. Ramp-up lag of 1–2 quarters for full utilization.
Risks the call surfaced
Thailand turnaround execution
HighThailand subsidiary 7 quarters post-acquisition with cumulative losses >₹200 Cr (implied). Cost structure fundamentally higher than India; management estimates 2–3 years to profitability. If timeline slips, cash burn accelerates.
Raw material volatility and cost pass-through
HighStyrene monomer prices volatile (₹1300–₹1600 range); management actively avoiding speculative procurement. Formula-based pricing for ABS/HIPS limits upside if input costs spike faster than customer passes through. Q2 NPM 2.3% reflects margin compression despite 24% revenue growth.
New ABS capacity ramp-up execution
MediumPhase 1 capex completion timeline vague (Jan-March FY27); even if on time, full utilization not guaranteed. Analyst skepticism evident: 'will it take 2 years to hit 100% utilization like competitors?' Management offered no utilization roadmap. If ramp is slow, EBITDA upside delays further.
Competitive intensity and import substitution
MediumKorean/Taiwanese competitors ramping ABS capacity in region; China dumping risk documented. Management maintains market share but pricing pressure evident. Commoditized GPPS grades are margin-dilutive; speculative volumes avoided. If regional competitive intensity increases, pricing power erodes.
Polystyrene demand softness
MediumNon-OEM polystyrene demand impacted by macro uncertainty. Management chose NOT to chase speculative GPPS volumes in Q2 due to price volatility and lack of committed demand. If polystyrene customer base further weakens (appliances, packaging), volume recovery delays.
Management
Score 6/10. Transparent on challenges (Thailand losses, polystyrene weakness, raw material volatility). However, vague on timelines: 'FY27 completion' for capex without month precision; '2–3 years' for Thailand breakeven without milestones. Avoids specific numbers on volume guidance. Mixed track record. ABS capacity expansion on stated timeline (reaffirmed prior guidance). Thailand acquisition has delivered cumulative losses >₹200 Cr in 7 quarters—significantly worse than implied turnaround expectations. India business stable; margin management adequate but reactive.
1 · Q3-Q4 FY27
Phase 1 ABS capacity (new refrigeration-liner grade) comes online; margin accretion begins
2 · Next 2-3 years
Thailand cost restructuring complete; operations become structurally profitable per management (unverified timeline)
3 · H2 FY27
New ASALAC and STYROLOY grades ramp volume; high-margin specialization increases
Near-term margin recovery hinges on Thailand cost restructuring (2+ years estimated) and raw material volatility easing—both uncertain.
Informational and educational content only. Not investment advice.